Core Viewpoint - The proposed reverse merger between ProPhase Labs, Inc. and Advanced Biological Laboratories S.A. aims to create a global, innovation-driven company that delivers near-term value for ProPhase shareholders and long-term growth for ABL [1][5]. Transaction Overview - A non-binding Letter of Intent (LOI) has been signed, indicating preliminary understandings without obligations to complete the transaction, pending due diligence and regulatory approvals [2][12]. - The proposed transaction may imply an enterprise value of up to approximately $30 million for ProPhase Labs, with a potential special cash dividend of up to $10 million for ProPhase shareholders [3][9]. Strategic Rationale - The merger is viewed as a significant strategic development for ProPhase, aligning it with ABL, a leader in molecular analysis and healthcare innovation, which can enhance the development of ProPhase's genomics and diagnostic programs [5][8]. - ABL shareholders are expected to own approximately 76% of the combined company post-merger, with a focus on operating ProPhase's Nebula Genomics platform and other health programs [6][10]. Asset and Liability Allocation - The combined entity will assume only specific liabilities, currently estimated at approximately $5 million, while other legacy liabilities will remain with ProPhase Labs [11]. - Current ProPhase shareholders will benefit from significant value carve-outs, including anticipated collections of approximately $50 million from Crown Medical Collections receivables [10]. Future Steps - The parties aim to finalize definitive agreements within approximately 60 to 90 days, with the transaction subject to customary closing conditions [4][12]. - A virtual conference call is scheduled for December 19, 2025, to present the proposed transaction to shareholders [13].

Core Viewpoint - Fund manager and activist investor Eric Jackson will lead a new crypto treasury firm after a reverse merger with SRx Health Solutions, a pet wellness company, resulting in a significant increase in the company's share price [1] Group 1 - The reverse merger is expected to enhance the company's position in the cryptocurrency sector [1] - SRx Health Solutions, previously focused on pet wellness, is pivoting towards the crypto market through this strategic move [1] - The announcement has led to a surge in the company's stock value, indicating strong market interest and investor confidence [1]

Core Insights - Clara, a buy now pay later platform, is launching its own stable coin, CLAUSD, to enhance payment efficiency and reduce costs [4][5] - Anamoka Brands plans to go public in the US through a reverse merger with a Singapore-based fintech firm, targeting a valuation of $1 billion by 2026 [6][9] Market Overview - Crypto markets are mixed, with economic data raising hopes for a potential rate cut in December, while consumer confidence has dropped to its lowest since April [2][3] - Bitcoin is trading just above $87,000, while Ether and XRP have seen increases of over 2% and 3% respectively [3] Anamoka Brands' Strategy - Anamoka Brands aims to leverage its extensive portfolio of over 600 companies to provide investors with access to the growing web3 ecosystem, focusing on altcoins rather than just Bitcoin and Ether [16][20] - The company reported $314 million in revenue and $97 million in EBITDA last year, positioning itself as a profitable operating business [19][20] Future Initiatives - Anamoka is set to launch a stable coin initiative and an RWA marketplace, expanding its offerings in the web3 space [21][28] - The company plans to continue investing in various sectors, including AI, DeFi, and gaming, while also supporting startups in the crypto industry [31][32]

Core Insights - Animoca Brands, a Hong Kong-based blockchain developer, plans to go public on Nasdaq through a reverse merger with Singapore-based fintech company Currenc [1][2] - This listing is significant as Animoca focuses on altcoins rather than exchanges or stablecoins, distinguishing it from other recent crypto offerings [2] - The merger will create the world's first publicly-listed diversified digital assets conglomerate, with Animoca shareholders owning 95% of the new entity [3] Company Overview - Animoca Brands has invested in over 600 blockchain companies, with notable past investments including the failed metaverse platform Sandbox [2] - The company has prior experience in public markets, having been listed on the Australian Securities Exchange before being delisted in 2020 due to compliance issues [6] Market Context - The reverse merger aligns with a trend where crypto companies prefer SPACs or reverse mergers to enter the stock market [4] - The altcoin market is currently facing challenges, having fallen $800 billion short of historical cycles, while retail investors in South Korea are turning to crypto-linked equities [6] - Despite the downturn, certain altcoins like Solana and Binance Coin have reached all-time highs in the past year [7]

Investment firm and crypto game publisher Animoca Brands plans to go public via a reverse merger, the Hong Kong-based firm said Monday. https://t.co/LnyuEVogCV ...

Crypto Giant Animoca Brands Eyes Nasdaq Debut via Reverse Merger► https://t.co/gt8xoY3bnb https://t.co/gt8xoY3bnb ...

Core Viewpoint - NewGenIVF Group Limited is pursuing a proposed reverse merger with SAXA, Inc. to acquire mining assets, which is expected to significantly enhance shareholder equity and transform NewGen into a multi-billion-dollar conglomerate [1][2][3] Proposed Transaction - NewGen plans to issue 500 million shares at US$10 each, totaling US$5 billion, to SAXA shareholders in exchange for specific mining assets valued at US$11 billion [2][4] - The assets include a gold and silver mine with 1.9 million ounces of gold and 4.4 million ounces of silver in measured reserves, and a planned US$1.5 billion dual processing facility for precious metals and rare earths [2][4] - Following the transaction, NewGen will issue an additional 50 million shares at US$5 each, raising US$250 million for further initiatives [4] Ownership Structure - Post-transaction, SAXA shareholders are expected to hold an 85.89% ownership stake in NewGen, with SAXA entitled to nominate a majority of the board of directors [5] Strategic Importance - The merger is positioned to capitalize on the increasing demand for critical minerals essential for U.S. national security and industrial applications, particularly in technologies like semiconductors and electric vehicles [2][3] - The combined entity aims to leverage SAXA's mining expertise and assets to enhance NewGen's diversified portfolio across various sectors [3][10] Company Background - NewGenIVF Group operates in real estate development, digital asset management, and reproductive health solutions, with a focus on innovative technology to drive growth [8] - SAXA, Inc. is an international holdings company with interests in diverse sectors, including mining, aiming to create a global footprint [10]

Company Strategy - Animoca Brands plans to list on Nasdaq through a reverse merger with Singapore's Currenc Group [1] - The target valuation for Animoca Brands is approximately $1 billion [1] Financial Performance - Animoca Brands reported revenue of $165 million in 2024 [1] - A significant portion of Animoca Brands' revenue comes from its digital asset advisory and portfolio management business [1]

As filed with the Securities and Exchange Commission on October 9, 2025. Registration No. 333-290589 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 3661 94-3336783 (I.R.S. Employer Identification Number) 4445 Eastgate Mall, Suite 200 San Diego, C ...

Company Overview - SSI International transitioned from financial struggles in 2023 to a successful Nasdaq listing in 2025, achieving a market cap exceeding $1 billion [1] - The company, founded by Sudhir Srivastava, has established itself in the medical technology sector, particularly in robotic surgical systems, competing with industry leader Intuitive Surgical [2] Business Development - SSI International has made significant progress since 2015, now shipping surgical systems weekly, with at least 115 units deployed across major hospitals in India and several other countries [3] - The company reported trailing 12-month revenue of $27.6 million as of June and has engaged an investment bank for public fundraising [4] Market Strategy - SSI went public through a merger with Avra Medical Robotics, allowing it to bypass traditional IPO processes [4] - The company aims to maintain capital efficiency in its operations, as emphasized by co-founder Shiladitya Sengupta [6] Industry Context - Vyome Therapeutics, another Indian biotech firm, successfully listed on Nasdaq via a reverse merger, highlighting a trend among Indian companies seeking alternative routes to public markets [5]